Impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammatory bowel disease centre

Author:

Scaldaferri Franco12ORCID,Pugliese Daniela1ORCID,Privitera Giuseppe2,Onali Sara1,Lopetuso Loris Riccardo1,Rizzatti Gianenrico1,Settanni Carlo Romano1,Pizzoferrato Marco1,Schiavoni Elisa1,Turchini Laura1,Amatucci Valeria1,Napolitano Daniele1,Bernabei Tiziana1,Mora Vincenzina1,Laterza Lucrezia1,Papa Alfredo12,Guidi Luisa12ORCID,Rapaccini Gian Lodovico12,Gasbarrini Antonio12,Armuzzi Alessandro12

Affiliation:

1. CEMAD – IBD UNIT – Unitá Operativa Complessa di Medicina Interna e Gastroenterologiac Fondazione Policlinico Universitario “A. Gemelli” IRCCSRomeItaly

2. Dipartimento Universitario di Medicina e Chirurgia TraslazionaleUniversità Cattolica del Sacro CuoreRomeItaly

Publisher

Wiley

Subject

Gastroenterology,Oncology

Reference14 articles.

1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. John Hopkins University.Coronavirus Resource Center coronavirus COVID‐19 global cases https://coronavirus.jhu.edu/map.html(2020 accessed 3 April2020).

4. Population Health Management for Inflammatory Bowel Disease

5. Quality of care standards in inflammatory bowel diseases: a European Crohn’s and Colitis Organisation (ECCO) position paper;Fiorino G;J Crohns Colitis,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3